{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T02:47:34Z","timestamp":1788576454418,"version":"build-2803163510"},"reference-count":85,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100009497","name":"The University of Texas at Arlington","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009497","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpain.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pain"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.jpain.2025.105486","type":"journal-article","created":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T10:16:14Z","timestamp":1751537774000},"page":"105486","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["A Multidimensional Preclinical Investigation of the Biogenic Amine Depletion and Subchronic Swim Models of Fibromyalgia"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-3964-9496","authenticated-orcid":false,"given":"Cassie M.","family":"Argenbright","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-5206-5189","authenticated-orcid":false,"given":"Ian F.","family":"Scully","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damaris","family":"Flores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Perry N.","family":"Fuchs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jpain.2025.105486_bib1","doi-asserted-by":"crossref","DOI":"10.1177\/15579883221110351","article-title":"Patients with fibromyalgia, depression, and\/or anxiety and sex differences","volume":"16","author":"Henao-Perez","year":"2022","journal-title":"Am J Mens Health"},{"issue":"8","key":"10.1016\/j.jpain.2025.105486_bib2","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.3390\/ijms22083891","article-title":"Fibromyalgia: pathogenesis, mechanisms, diagnosis and treatment options update","volume":"22","author":"Siracusa","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.jpain.2025.105486_bib3","first-page":"1065","article-title":"Fibromyalgia: one year in review 2022","volume":"40","author":"Giorgi","year":"2022","journal-title":"Clin Exp Rheuma"},{"issue":"3","key":"10.1016\/j.jpain.2025.105486_bib4","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.semarthrit.2016.08.012","article-title":"2016 Revisions to the 2010\/2011 fibromyalgia diagnostic criteria","volume":"46","author":"Wolfe","year":"2016","journal-title":"Semin Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.jpain.2025.105486_bib5","first-page":"30","article-title":"Multidisciplinary modalities in the treatment of fibromyalgia","volume":"69","author":"Goldenberg","year":"2008","journal-title":"J Clin Psychiatry"},{"issue":"4","key":"10.1016\/j.jpain.2025.105486_bib6","doi-asserted-by":"crossref","first-page":"206","DOI":"10.4081\/reumatismo.2012.206","article-title":"Fibromyalgia dyscognition: concepts and issues","volume":"64","author":"Ambrose","year":"2012","journal-title":"Reumatismo"},{"issue":"3","key":"10.1016\/j.jpain.2025.105486_bib7","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jad.2010.07.004","article-title":"Fibromyalgia syndrome and depressive symptoms: comorbidity and clinical correlates","volume":"128","author":"Aguglia","year":"2011","journal-title":"J Affect Disord"},{"issue":"9","key":"10.1016\/j.jpain.2025.105486_bib8","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1111\/j.1742-1241.2007.01480.x","article-title":"Characteristics and healthcare costs of patients with fibromyalgia syndrome","volume":"61","author":"Berger","year":"2007","journal-title":"Int J Clin Pr"},{"issue":"9","key":"10.1016\/j.jpain.2025.105486_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0138024","article-title":"The prevalence and characteristics of fibromyalgia in the 2012 National health interview survey","volume":"10","author":"Walitt","year":"2015","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.jpain.2025.105486_bib10","doi-asserted-by":"crossref","first-page":"168","DOI":"10.4103\/injr.injr_52_18","article-title":"Anxiety and depression are common in fibromyalgia patients and correlate with symptom severity score","volume":"13","author":"Singh","year":"2018","journal-title":"Indian J Rheumatol"},{"key":"10.1016\/j.jpain.2025.105486_bib11","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1471-2474-8-27","article-title":"An internet survey of 2,596 people with fibromyalgia","volume":"8","author":"Bennett","year":"2007","journal-title":"BMC Musculoskelet Disord"},{"issue":"7","key":"10.1016\/j.jpain.2025.105486_bib12","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1007\/s00296-014-3208-7","article-title":"Fibrofog and fibromyalgia: a narrative review and implications for clinical practice","volume":"35","author":"Kravitz","year":"2015","journal-title":"Rheuma Int"},{"issue":"11","key":"10.1016\/j.jpain.2025.105486_bib13","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/s41584-020-00506-w","article-title":"Fibromyalgia: an update on clinical characteristics, aetiopathogenesis and treatment","volume":"16","author":"Sarzi-Puttini","year":"2020","journal-title":"Nat Rev Rheuma"},{"issue":"10","key":"10.1016\/j.jpain.2025.105486_bib14","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.3899\/jrheum.090367","article-title":"Fibromyalgia syndrome module at OMERACT 9: domain construct","volume":"36","author":"Mease","year":"2009","journal-title":"J Rheuma"},{"key":"10.1016\/j.jpain.2025.105486_bib15","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/7261468","article-title":"Differences in multidisciplinary and interdisciplinary treatment programs for fibromyalgia: a mapping review","author":"Giusti","year":"2017","journal-title":"Pain Res Manag"},{"key":"10.1016\/j.jpain.2025.105486_bib16","series-title":"Treatments for fibromyalgia in adult subgroups","author":"Forte","year":"2015"},{"issue":"5","key":"10.1016\/j.jpain.2025.105486_bib17","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.12939","article-title":"Comparison of amitriptyline and US food and drug administration-approved treatments for fibromyalgia: a systematic review and network meta-analysis","volume":"5","author":"Farag","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1016\/j.jpain.2025.105486_bib18","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1001\/jamainternmed.2020.5651","article-title":"Association of therapies with reduced pain and improved quality of life in patients with fibromyalgia: a systematic review and meta-analysis","volume":"181","author":"Mascarenhas","year":"2021","journal-title":"JAMA Intern Med"},{"issue":"5","key":"10.1016\/j.jpain.2025.105486_bib19","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s40273-014-0137-y","article-title":"Fibromyalgia: disease synopsis, medication cost effectiveness and economic burden","volume":"32","author":"Skaer","year":"2014","journal-title":"Pharmacoeconomics"},{"issue":"1","key":"10.1016\/j.jpain.2025.105486_bib20","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3233\/BMR-200282","article-title":"Effectiveness of non-pharmacological conservative therapies in adults with fibromyalgia: a systematic review of high-quality clinical trials","volume":"35","author":"Hernando-Garijo","year":"2022","journal-title":"J Back Musculoskelet Rehabil"},{"key":"10.1016\/j.jpain.2025.105486_bib21","author":"Soliman","year":"2023","journal-title":"Anim Models Transl Pain Res IASP Glob Year Transl Pain Knowl Pract"},{"issue":"1","key":"10.1016\/j.jpain.2025.105486_bib22","first-page":"15","article-title":"Current challenges of research into fibromyalgia: from clinical studies to animal models a brief overview of fibromyalgia","volume":"1","author":"Hung","year":"2015","journal-title":"Fibrom Open"},{"issue":"4","key":"10.1016\/j.jpain.2025.105486_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12040778","article-title":"The fibromyalgia pain experience: a scoping review of the preclinical evidence for replication and treatment of the affective and cognitive pain dimensions","volume":"12","author":"Argenbright","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.jpain.2025.105486_bib24","doi-asserted-by":"crossref","DOI":"10.1186\/ar4402","article-title":"Animal models of fibromyalgia","volume":"15","author":"Desantana","year":"2013","journal-title":"Arthritis Res Ther"},{"issue":"7","key":"10.1016\/j.jpain.2025.105486_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines8070223","article-title":"Key milestones contributing to the understanding of the mechanisms underlying fibromyalgia","volume":"8","author":"Littlejohn","year":"2020","journal-title":"Biomedicines"},{"key":"10.1016\/j.jpain.2025.105486_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fpain.2023.1097457","article-title":"Pregabalin and hyperbaric oxygen therapy on pain thresholds and anxio-depressive behaviors in a preclinical fibromyalgia pain model","volume":"4","author":"Argenbright","year":"2023","journal-title":"Front Pain Res"},{"issue":"1-2","key":"10.1016\/j.jpain.2025.105486_bib27","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.pain.2009.05.024","article-title":"Biogenic amine depletion causes chronic muscular pain and tactile allodynia accompanied by depression: a putative animal model of fibromyalgia","volume":"146","author":"Nagakura","year":"2009","journal-title":"Pain"},{"issue":"3","key":"10.1016\/j.jpain.2025.105486_bib28","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0091-3057(00)00374-9","article-title":"Long-lasting delayed hyperalgesia after subchronic swim stress","volume":"67","author":"Quintero","year":"2000","journal-title":"Pharm Biochem Behav"},{"key":"10.1016\/j.jpain.2025.105486_bib29","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1146\/annurev.pa.20.040180.002301","article-title":"Efficient analysis of experimental observations","volume":"20","author":"Dixon","year":"1980","journal-title":"Annu Rev Pharm Toxicol"},{"issue":"2","key":"10.1016\/j.jpain.2025.105486_bib30","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.bbr.2004.04.020","article-title":"Susceptibility to subchronic unpredictable stress is related to individual reactivity to threat stimuli in mice","volume":"155","author":"Ducottet","year":"2004","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.jpain.2025.105486_bib31","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.beproc.2013.08.008","article-title":"The usefulness of olfactory fear conditioning for the study of early emotional and cognitive impairment in reserpine model","volume":"100","author":"Souza","year":"2013","journal-title":"Behav Process"},{"key":"10.1016\/j.jpain.2025.105486_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.107959","article-title":"Animal models of fibromyalgia: what is the best choice?","volume":"230","author":"Brum","year":"2022","journal-title":"Pharmacol Ther"},{"issue":"10","key":"10.1016\/j.jpain.2025.105486_bib33","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/j.psyneuen.2011.04.012","article-title":"Curcumin ameliorates reserpine-induced pain-depression dyad: behavioural, biochemical, neurochemical and molecular evidences","volume":"36","author":"Arora","year":"2011","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.jpain.2025.105486_bib34","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.toxicon.2014.01.015","article-title":"The effects of Phalpha1beta, a spider toxin, calcium channel blocker, in a mouse fibromyalgia model","volume":"81","author":"de Souza","year":"2014","journal-title":"Toxicon"},{"key":"10.1016\/j.jpain.2025.105486_bib35","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.neulet.2016.01.025","article-title":"Effect of spinal monoaminergic neuronal system dysfunction on pain threshold in rats, and the analgesic effect of serotonin and norepinephrine reuptake inhibitors","volume":"615","author":"Tamano","year":"2016","journal-title":"Neurosci Lett"},{"issue":"5","key":"10.1016\/j.jpain.2025.105486_bib36","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/FBP.0000000000000454","article-title":"Effects of imidazoline I2 receptor agonists on reserpine-induced hyperalgesia and depressive-like behavior in rats","volume":"30","author":"Siemian","year":"2019","journal-title":"Behav Pharm"},{"issue":"12","key":"10.1016\/j.jpain.2025.105486_bib37","doi-asserted-by":"crossref","first-page":"628","DOI":"10.3390\/antiox8120628","article-title":"Melatonin plus folic acid treatment ameliorates reserpine-induced fibromyalgia: an evaluation of pain, oxidative stress, and inflammation","volume":"8","author":"Fusco","year":"2019","journal-title":"Antioxidants"},{"issue":"6","key":"10.1016\/j.jpain.2025.105486_bib38","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1097\/j.pain.0000000000001513","article-title":"Nociceptin\/orphanin FQ receptor modulates painful and fatigue symptoms in a mouse model of fibromyalgia","volume":"160","author":"Dagnino","year":"2019","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2025.105486_bib39","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.31885\/jrn.1.2020.1431","article-title":"IdS. Kinin B1 receptor is involved in mechanical nociception in a fibromyalgia-like model in mice","volume":"1","author":"Dagnino","year":"2020","journal-title":"J Reprod Neurosci"},{"issue":"4","key":"10.1016\/j.jpain.2025.105486_bib40","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s11011-013-9404-4","article-title":"Ferulic acid increases pain threshold and ameliorates depression-like behaviors in reserpine-treated mice: behavioral and neurobiological analyses","volume":"28","author":"Xu","year":"2013","journal-title":"Metab Brain Dis"},{"key":"10.1016\/j.jpain.2025.105486_bib41","article-title":"Coadministration of resveratrol and rice oil mitigates nociception and oxidative state in a mouse fibromyalgia-like model","author":"Klein","year":"2016","journal-title":"Pain Res Treat"},{"key":"10.1016\/j.jpain.2025.105486_bib42","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.neuropharm.2014.05.043","article-title":"Effects of D-series resolvins on behavioral and neurochemical changes in a fibromyalgia-like model in mice","volume":"86","author":"Klein","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jpain.2025.105486_bib43","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.physbeh.2015.07.033","article-title":"Depressive-like symptoms in a reserpine-induced model of fibromyalgia in rats","volume":"151","author":"Blasco-Serra","year":"2015","journal-title":"Physiol Behav"},{"key":"10.1016\/j.jpain.2025.105486_bib44","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.ejphar.2016.10.021","article-title":"Pain-depression dyad induced by reserpine is relieved by p,p'-methoxyl-diphenyl diselenide in rats","volume":"791","author":"Oliveira","year":"2016","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jpain.2025.105486_bib45","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.physbeh.2018.07.007","article-title":"Monoamine system disruption induces functional somatic syndromes associated symptomatology in mice","volume":"194","author":"Nagakura","year":"2018","journal-title":"Physiol Behav"},{"key":"10.1016\/j.jpain.2025.105486_bib46","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.bcp.2019.06.023","article-title":"Kinins and their B1 and B2 receptors are involved in fibromyalgia-like pain symptoms in mice","volume":"168","author":"Brusco","year":"2019","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jpain.2025.105486_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172716","article-title":"Spontaneous pain-associated facial expression and efficacy of clinically used drugs in the reserpine-induced rat model of fibromyalgia","volume":"864","author":"Nagakura","year":"2019","journal-title":"Eur J Pharm"},{"issue":"2","key":"10.1016\/j.jpain.2025.105486_bib48","first-page":"1343","article-title":"Attenuation of reserpine-induced fibromyalgia via ROS and serotonergic pathway modulation by fisetin, a plant flavonoid polyphenol","volume":"19","author":"Yao","year":"2020","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.jpain.2025.105486_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2020.104673","article-title":"Involvement of TRPV1 and the efficacy of alpha-spinasterol on experimental fibromyalgia symptoms in mice","volume":"134","author":"Fischer","year":"2020","journal-title":"Neurochem Int"},{"issue":"10","key":"10.1016\/j.jpain.2025.105486_bib50","doi-asserted-by":"crossref","first-page":"4202","DOI":"10.1007\/s12035-020-01996-1","article-title":"Relevance of mitochondrial dysfunction in the reserpine-induced experimental fibromyalgia model","volume":"57","author":"Brum","year":"2020","journal-title":"Mol Neurobiol"},{"issue":"4","key":"10.1016\/j.jpain.2025.105486_bib51","first-page":"269","article-title":"Traditional herbal medicine yukmijihwang-won alleviates reserpine-induced pain and depression-like behavior in mice","volume":"31","author":"Kang","year":"2020","journal-title":"J Orient Neuropsychiatry"},{"issue":"8","key":"10.1016\/j.jpain.2025.105486_bib52","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.3390\/molecules26082398","article-title":"Serotonergic neurotransmission system modulator, vortioxetine, and dopaminergic D2\/D3 receptor agonist, ropinirole, attenuate fibromyalgia-like symptoms in mice","volume":"26","author":"Sa\u0142at","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.jpain.2025.105486_bib53","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.toxicon.2021.03.012","article-title":"Effects of intravenous administration of recombinant Ph\u03b11\u03b2 toxin in a mouse model of fibromyalgia","volume":"195","author":"Mendes","year":"2021","journal-title":"Toxicon"},{"key":"10.1016\/j.jpain.2025.105486_bib54","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.neuroscience.2021.04.017","article-title":"Exercise reduces pain and deleterious histological effects in fibromyalgia-like model","volume":"465","author":"Ferrarini","year":"2021","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/j.jpain.2025.105486_bib55","doi-asserted-by":"crossref","first-page":"450","DOI":"10.4103\/1673-5374.317984","article-title":"Pramipexole, a dopamine D3\/D2 receptor-preferring agonist, attenuates reserpine-induced fibromyalgia-like model in mice","volume":"17","author":"Martins","year":"2022","journal-title":"Neural Regen Res"},{"issue":"1","key":"10.1016\/j.jpain.2025.105486_bib56","doi-asserted-by":"crossref","first-page":"9719","DOI":"10.1038\/s41598-022-13968-7","article-title":"Long-lasting reflexive and nonreflexive pain responses in two mouse models of fibromyalgia-like condition","volume":"12","author":"Alvarez-Perez","year":"2022","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.jpain.2025.105486_bib57","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1186\/s12888-022-04065-0","article-title":"Alterations of monoamine neurotransmitters, HPA-axis hormones, and inflammation cytokines in reserpine-induced hyperalgesia and depression comorbidity rat model","volume":"22","author":"Zhao","year":"2022","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.jpain.2025.105486_bib58","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.bcp.2019.05.012","article-title":"Ameliorative effect of imperatorin in chemically induced fibromyalgia: Role of NMDA\/NFkB mediated downstream signaling","volume":"166","author":"Kaur","year":"2019","journal-title":"Biochem Pharm"},{"issue":"11","key":"10.1016\/j.jpain.2025.105486_bib59","doi-asserted-by":"crossref","first-page":"3700","DOI":"10.1111\/1750-3841.15476","article-title":"Optimization of extraction conditions of Angelica archangelica extract and activity evaluation in experimental fibromyalgia","volume":"85","author":"Kaur","year":"2020","journal-title":"J Food Sci"},{"issue":"10","key":"10.1016\/j.jpain.2025.105486_bib60","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1007\/s11064-020-03095-y","article-title":"Protective effect of esculetin, natural coumarin in mice model of fibromyalgia: targeting pro-inflammatory cytokines and MAO-A","volume":"45","author":"Singh","year":"2020","journal-title":"Neurochem Res"},{"issue":"5","key":"10.1016\/j.jpain.2025.105486_bib61","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1007\/s00221-021-06064-1","article-title":"Daphnetin, a natural coumarin averts reserpine-induced fibromyalgia in mice: modulation of MAO-A","volume":"239","author":"Singh","year":"2021","journal-title":"Exp Brain Res"},{"key":"10.1016\/j.jpain.2025.105486_bib62","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.bbr.2018.01.005","article-title":"Sleep architecture is altered in the reserpine-induced fibromyalgia model in ovariectomized rats","volume":"364","author":"Hernandez-Leon","year":"2019","journal-title":"Behav Brain Res"},{"issue":"4","key":"10.1016\/j.jpain.2025.105486_bib63","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1097\/j.pain.0000000000000827","article-title":"Chronic stress exacerbates neuropathic pain via the integration of stress-affect-related information with nociceptive information in the central nucleus of the amygdala","volume":"158","author":"Li","year":"2017","journal-title":"Pain"},{"issue":"2","key":"10.1016\/j.jpain.2025.105486_bib64","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1097\/j.pain.0000000000001734","article-title":"Low catechol-O-methyltransferase and stress potentiate functional pain and depressive behavior, especially in female mice","volume":"161","author":"Zhang","year":"2020","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2025.105486_bib65","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.neuroscience.2020.05.044","article-title":"Down-regulation of Spinal 5-HT and 5-HT receptors contributes to somatic hyperalgesia induced by orofacial inflammation combined with stress","volume":"440","author":"Xue","year":"2020","journal-title":"Neuroscience"},{"key":"10.1016\/j.jpain.2025.105486_bib66","article-title":"Involvement of parvalbumin-positive neurons in the development of hyperalgesia in a mouse model of fibromyalgia","volume":"2","author":"Miyahara","year":"2021","journal-title":"Front Pain Res (Lausanne)"},{"key":"10.1016\/j.jpain.2025.105486_bib67","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.brainresbull.2018.07.007","article-title":"Alpha- (phenylselanyl) acetophenone mitigates reserpine-induced pain-depression dyad: Behavioral, biochemical and molecular docking evidences","volume":"142","author":"Sousa","year":"2018","journal-title":"Brain Res Bull"},{"issue":"7","key":"10.1016\/j.jpain.2025.105486_bib68","article-title":"Cationic liposome-encapsulated carotenoids as a potential treatment for fibromyalgia in an animal model","volume":"1867","author":"Elkholy","year":"2021","journal-title":"Biochim Et Biophys Acta-Mol Basis Dis"},{"key":"10.1016\/j.jpain.2025.105486_bib69","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.physbeh.2014.02.054","article-title":"Role of nitric oxide in altered nociception and memory following chronic stress","volume":"129","author":"Nazeri","year":"2014","journal-title":"Physiol Behav"},{"issue":"1","key":"10.1016\/j.jpain.2025.105486_bib70","doi-asserted-by":"crossref","first-page":"93","DOI":"10.4103\/2277-9175.183141","article-title":"Simultaneous impairment of passive avoidance learning and nociception in rats following chronic swim stress","volume":"5","author":"Nazeri","year":"2016","journal-title":"Adv Biomed Res"},{"issue":"8","key":"10.1016\/j.jpain.2025.105486_bib71","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.jpain.2012.04.006","article-title":"Mechanical and heat hyperalgesia highly predict clinical pain intensity in patients with chronic musculoskeletal pain syndromes","volume":"13","author":"Staud","year":"2012","journal-title":"J Pain"},{"issue":"5","key":"10.1016\/j.jpain.2025.105486_bib72","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/hup.696","article-title":"Safety and tolerability of duloxetine in the treatment of major depressive disorder: analysis of pooled data from eight placebo-controlled clinical trials","volume":"20","author":"Hudson","year":"2005","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.jpain.2025.105486_bib73","first-page":"99","article-title":"Duloxetine for the management of fibromyalgia syndrome","volume":"2","author":"Scholz","year":"2009","journal-title":"J Pain Res"},{"key":"10.1016\/j.jpain.2025.105486_bib74","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jpsychores.2017.03.011","article-title":"Sleep disturbances in fibromyalgia: a meta-analysis of case-control studies","volume":"96","author":"Wu","year":"2017","journal-title":"J Psychosom Res"},{"issue":"6","key":"10.1016\/j.jpain.2025.105486_bib75","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/j.1742-7843.2009.00525.x","article-title":"Protective effect of epigallocatechin gallate in murine water-immersion stress model of chronic fatigue syndrome","volume":"106","author":"Sachdeva","year":"2010","journal-title":"Basic Clin Pharm Toxicol"},{"issue":"2","key":"10.1016\/j.jpain.2025.105486_bib76","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1093\/pm\/pnx114","article-title":"Evidence of altered trigeminal nociception in an animal model of fibromyalgia","volume":"19","author":"Nazeri","year":"2018","journal-title":"Pain Med"},{"key":"10.1016\/j.jpain.2025.105486_bib77","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/732845","article-title":"Effects of electroacupuncture with dominant frequency at SP 6 and ST 36 based on meridian theory on pain-depression dyad in rats","volume":"2015","author":"Wu","year":"2015","journal-title":"Evid-Based Complement Altern Med"},{"issue":"4","key":"10.1016\/j.jpain.2025.105486_bib78","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.pbb.2008.02.011","article-title":"Venlafaxine reverses chronic fatigue-induced behavioral, biochemical and neurochemical alterations in mice","volume":"89","author":"Dhir","year":"2008","journal-title":"Pharm Biochem Behav"},{"issue":"3","key":"10.1016\/j.jpain.2025.105486_bib79","article-title":"Hydroalcoholic extract of Glycyrrhiza glabra linn. attentuates chronic fatigue stress induced behavioral alterations in mice","volume":"2","author":"Trivedi","year":"2011","journal-title":"Int J Pharm Biol Arch"},{"key":"10.1016\/j.jpain.2025.105486_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2022.114046","article-title":"Short-term stress significantly decreases morphine analgesia in trigeminal but not in spinal innervated areas in rats","volume":"435","author":"Bagues","year":"2022","journal-title":"Behav Brain Res"},{"issue":"9","key":"10.1016\/j.jpain.2025.105486_bib81","doi-asserted-by":"crossref","first-page":"6239","DOI":"10.1007\/s12035-019-1522-5","article-title":"Tactile stimulation on adulthood modifies the HPA axis, neurotrophic factors, and GFAP signaling reverting depression-like behavior in female rats","volume":"56","author":"Roversi","year":"2019","journal-title":"Mol Neurobiol"},{"issue":"6","key":"10.1016\/j.jpain.2025.105486_bib82","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/j.pnpbp.2008.05.004","article-title":"Memory impairment induced by low doses of reserpine in rats: possible relationship with emotional processing deficits in Parkinson disease","volume":"32","author":"Fernandes","year":"2008","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"5","key":"10.1016\/j.jpain.2025.105486_bib83","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1080\/09553002.2017.1270475","article-title":"Evidences for amelioration of reserpine-induced fibromyalgia in rat by low dose of gamma irradiation and duloxetine","volume":"93","author":"Shibrya","year":"2017","journal-title":"Int J Radiat Biol"},{"key":"10.1016\/j.jpain.2025.105486_bib84","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.neulet.2017.08.019","article-title":"A standardization of the Novelty-Suppressed Feeding Test protocol in rats","volume":"658","author":"Blasco-Serra","year":"2017","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.jpain.2025.105486_bib85","series-title":"Changes in GRK3 and Norepinephrine Responsiveness in Locus Coeruleus Neurons are Associated with Learned Helplessness After Repeated Forced Swim Stress","author":"Saha","year":"2011"}],"container-title":["The Journal of Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526590025007138?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526590025007138?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T03:36:57Z","timestamp":1788233817000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526590025007138"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":85,"alternative-id":["S1526590025007138"],"URL":"https:\/\/doi.org\/10.1016\/j.jpain.2025.105486","relation":{},"ISSN":["1526-5900"],"issn-type":[{"value":"1526-5900","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Multidimensional Preclinical Investigation of the Biogenic Amine Depletion and Subchronic Swim Models of Fibromyalgia","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pain","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpain.2025.105486","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 Published by Elsevier Inc. on behalf of United States Association for the Study of Pain, Inc","name":"copyright","label":"Copyright"}],"article-number":"105486"}}